Absence of mitochondrial activation during levosimendan inotropic action in perfused paced guinea pig hearts as demonstrated by modular control analysis

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 299, Issue 3, 2010, Pages

  Deschodt Arsac, Véronique ^a   Calmettes, Guillaume ^a   Raffard, Gérard ^a   Massot, Philippe ^a   Franconi, Jean Michel ^a   Pollesello, Piero ^b   Diolez, Philippe ^a  

^a CNRS University Bordeaux Segalen   (France)

^b ORION CORPORATION   (Finland)

Author keywords

Calcium sensitizer; Mitochondria; Modular control analysis; Oxygen consumption; Phosphate 31 magnetic resonance spectroscopy; Systems biology

Indexed keywords

ANTIARRHYTHMIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ANIMAL; DRUG EFFECTS; GUINEA PIG; HEART; HEART CONTRACTION; HEART MITOCHONDRION; HEART MUSCLE; MALE; METABOLISM; OXYGEN CONSUMPTION; PHYSIOLOGY;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; GUINEA PIGS; HEART; HYDRAZONES; MALE; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXYGEN CONSUMPTION; PYRIDAZINES;

EID: 77956654479     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00184.2010     Document Type: Article

References (65)

1. Ainscow EK, Brand MD. Errors associated with metabolic control analysis. Application of Monte-Carlo simulation of experimental data. J Theor Biol 194: 223-233, 1998.
2. Ainscow EK, Brand MD. Quantifying elasticity analysis: how external effectors cause changes to metabolic systems. BioSystems 49: 151-159, 1999.
3. Allen DG, Kurihara S. The effects of muscle length on intracellular calcium transients in mammalian cardiac muscle. J Physiol 327: 79-94, 1982. (Pubitemid 12086440)
4. Balaban RS. Cardiac energy metabolism homeostasis: role of cytosolic calcium. J Mol Cell Cardiol 34: 1259-1271, 2002.
5. Balaban RS, Bose S, French SA, Territo PR. Role of calcium in metabolic signaling between cardiac sarcoplasmic reticulum and mitochondria in vitro. Am J Physiol Cell Physiol 284: C285-C293, 2003.
6. Banfor PN, Preusser LC, Campbell TJ, Marsh KC, Polakowski JS, Reinhart GA, Cox BF, Fryer RM. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol 294: H238-H248, 2008.
7. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
8. Brand MD. Top down metabolic control analysis. J Theor Biol 182: 351-360, 1996.
9. Brand MD, Chien LF, Diolez P. Experimental discrimination between proton leak and redox slip during mitochondrial electron transport. Biochem J 297: 27-29, 1994. (Pubitemid 24025597)
10. Brand MD, Curtis RK. Simplifying metabolic complexity. Biochem Soc Trans 30: 25-30, 2002.
11. Brown GC, Hafner RP, Brand MD. A top down approach to the determination of control coefficients in metabolic control theory. Eur J Biochem 188: 321-325, 1990.
12. Calmettes G, Deschodt-Arsac V, Gouspillou G, Miraux S, Muller B, Franconi JM, Thiaudiere E, Diolez P. Improved energy supply regulation in chronic hypoxic mouse counteracts hypoxia-induced altered cardiac energetics. PLoS One 5: e9306.
13. Calmettes G, Deschodt-Arsac V, Thiaudiere E, Muller B, Diolez P. Modular control analysis of effects of chronic hypoxia on mouse heart. Am J Physiol Regul Integr Comp Physiol 295: R1891-R1897, 2008.
14. Delgado JF. Levosimendan in acute heart failure: past, present and future. Rev Esp Cardiol 59: 309-312, 2006. (Pubitemid 43833834)
15. Diolez P, Deschodt-Arsac V, Raffard G, Simon C, Santos PD, Thiaudiere E, Arsac L, Franconi JM. Modular regulation analysis of heart contraction: application to in situ demonstration of a direct mitochondrial activation by calcium in beating heart. Am J Physiol Regul Integr Comp Physiol 293: R13-R19, 2007. (Pubitemid 47092156)
16. Diolez P, Raffard G, Simon C, Leducq N, Dos Santos P, Canioni P. Mitochondria do not control heart bioenergetics. Molecular Biology Reports 29: 193-196, 2002. (Pubitemid 35021885)
17. Dos Santos P, Aliev MK, Diolez P, Duclos F, Besse P, Bonoron-Adele S, Sikk P, Canioni P, Saks VA. Metabolic control of contractile performance in isolated perfused rat heart. Analysis Of experimental data by Reaction:Diffusion mathematical model. J Mol Cell Cardiol 32: 1703-1734, 2000.
18. Dufour S, Rousse N, Canioni P, Diolez P. Top-down control analysis of temperature effect on oxidative phosphorylation. Biochem J 314: 743-751, 1996. (Pubitemid 126732818)
19. Du Toit EF, Muller CA, McCarthy J, Opie LH. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart. J Pharmacol Exp Ther 290: 505-514, 1999. (Pubitemid 29344540)
20. 2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res 77: 107-113, 1995.
21. 2+ signaling in intact myocardium. J Pharmacol Sci 100: 525-537, 2006.
22. Eriksson O, Pollesello P, Haikala H. Effect of levosimendan on balance between ATP production and consumption in isolated perfused guinea-pig heart before ischemia or after reperfusion. J Cardiovasc Pharmacol 44: 316-321, 2004. (Pubitemid 39129449)
23. Fell DA. Metabolic control analysis: a survey of its theoretical and experimental development. Biochem J 286: 313-330, 1992.
24. Gonzalvez F, Pariselli F, Dupaigne P, Budihardjo I, Lutter M, Antonsson B, Diolez P, Manon S, Martinou JC, Goubern M, Wang X, Bernard S, Petit PX. tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak (Abstract). Cell Death Differ 8: 8, 2005.
25. Haikala H, Kaheinen P, Levijoki J, Linden IB. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan. Cardiovasc Res 34: 536-546, 1997. (Pubitemid 27272673)
26. Haikala H, Linden IB. Mechanisms of action of calcium-sensitizing drugs. J Cardiovasc Pharmacol 26, Suppl 1: S10-S19, 1995.
27. Haikala H, Nissinen E, Etemadzadeh E, Levijoki J, Linden IB. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 25: 794-801, 1995.
28. Harris DA, Das AM. Control of mitochondrial ATP synthesis in the heart. Biochem J 280: 561-573, 1991.
29. Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 98: 2141-2147, 1998. (Pubitemid 28527473)
30. Heinrich R, Rapoport TA. A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. Eur J Biochem 42: 89-95, 1974.
31. Hibberd MG, Jewell BR. Calcium- and length-dependent force production in rat ventricular muscle. J Physiol 329: 527-540, 1982.
32. Kacser H, Burns JA. The control of flux. Symp Soc Exp Biol 27: 65-104, 1973.
33. 2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition. Basic Clin Pharmacol Toxicol 98: 74-78, 2006.
34. Kaheinen P, Pollesello P, Levijoki J, Haikala H. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart. J Cardiovasc Pharmacol 43: 555-561, 2004. (Pubitemid 39090022)
35. Kaheinen P, Pollesello P, Levijoki J, Haikala H. Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels. J Cardiovasc Pharmacol 37: 367-374, 2001. (Pubitemid 32240418)
36. Katz AM. Ernest Henry Starling, his predecessors, and the "Law of the Heart". Circulation 106: 2986-2992, 2002.
37. Kavanagh NI, Ainscow EK, Brand MD. Calcium regulation of oxidative phosphorylation in rat skeletal muscle mitochondria. Biochim Biophys Acta 1457: 57-70, 2000. (Pubitemid 30110730)
38. 2+ concentration after length changes in isolated rat ventricular trabeculae. J Physiol 506: 431-444, 1998.
39. Kojima S, Wu ST, Parmley WW, Wikman-Coffelt J. Relationship between intracellular calcium and oxygen consumption: effects of perfusion pressure, extracellular calcium, dobutamine, and nifedipine. Am Heart J 127: 386-391, 1994. (Pubitemid 24063232)
40. Kopustinskiene DM, Pollesello P, Saris NE. Potassium-specific effects of levosimendan on heart mitochondria. Biochem Pharmacol 68: 807-812, 2004. (Pubitemid 39044509)
41. Korzeniewski B. Regulation of ATP supply during muscle contraction: theoretical studies. Biochem J 330: 1189-1195, 1998. (Pubitemid 28161993)
42. Korzeniewski B, Deschodt-Arsac V, Calmettes G, Franconi JM, Diolez PH. Physiological heart activation by adrenaline involves parallel activation of ATP usage and supply. Biochem J 413: 343-347, 2008.
43. Korzeniewski B, Deschodt-Arsac V, Calmettes G, Gouspillou G, Franconi JM, Diolez P. Effect of pyruvate, lactate and insulin on ATP supply and demand in unpaced perfused rat heart. Biochem J 423: 421-428, 2009.
44. Korzeniewski B, Harper ME, Brand MD. Proportional activation coefficients during stimulation of oxidative phosphorylation by lactate and pyruvate or by vasopressin. Biochim Biophys Acta 1229: 315-322, 1995.
45. Korzeniewski B, Noma A, Matsuoka S. Regulation of oxidative phosphorylation in intact mammalian heart in vivo. Biophys Chem 116: 145-157, 2005. (Pubitemid 40799384)
46. i in guinea-pig isolated ventricular myocytes. Eur J Pharmacol 339: 97-100, 1997.
47. Leducq N, Delmas-Beauvieux MC, Bourdel-Marchasson I, Dufour S, Gallis JL, Canioni P, Diolez P. Characterization of mitochondrial dysfunction of the perfused rat liver during the transition from hypo-tonormothermia: protective effect of cyclosporin A. Biochem J 336: 501-506, 1998. (Pubitemid 28564409)
48. MacGowan GA. The myofilament force-calcium relationship as a target for positive inotropic therapy in congestive heart failure. Cardiovasc Drugs Ther 19: 203-210, 2005.
49. MacGowan GA, Kirk JA, Evans C, Shroff SG. Pressure-calcium relationships in perfused mouse hearts. Am J Physiol Heart Circ Physiol 290: H2614-H2624, 2006.
50. Mildaziene V, Baniene R, Nauciene Z, Bakker BM, Brown GC, Westerhoff HV, Kholodenko BN. Calcium indirectly increases the control exerted by the adenine nucleotide translocator over 2-oxoglutarate oxidation in rat heart mitochondria. Arch Biochem Biophys 324: 130-134, 1995.
51. Mizuno J, Araki J, Mohri S, Minami H, Doi Y, Fujinaka W, Miyaji K, Kiyooka T, Oshima Y, Iribe G, Hirakawa M, Suga H. Frank-Starling mechanism retains recirculation fraction of myocardial Ca(2+) in the beating heart. Jpn J Physiol 51: 733-743, 2001. (Pubitemid 33814847)
52. Nicholls DG. The non-Ohmic proton leak-25 years on. Biosci Rep 17: 251-257, 1997.
53. Nieminen MS, Pollesello P, Vajda G, Papp Z. Effects of levosimendan on the energy balance: preclinical and clinical evidence. J Cardiovasc Pharmacol 53: 302-310, 2009.
54. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML. Effect of oral milrinone on mortality in severe chronic heart failure The PROMISE Study Research Group. N Engl J Med 325: 1468-1475, 1991.
55. Pagel PS, Hettrick DA, Warltier DC. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency. Basic Res Cardiol 91: 296-307, 1996.
56. Papp Z, Csapo K, Pollesello P, Haikala H, Edes I. Pharmacological mechanisms contributing to the clinical efficacy of levosimendan. Cardiovasc Drug Rev 23: 71-98, 2005. (Pubitemid 40571678)
57. Petit PX, Goubern M, Diolez P, Susin SA, Zamzami N, Kroemer G. Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: the impact of irreversible permeability transition. FEBS Lett 426: 111-116, 1998. (Pubitemid 28198166)
58. 2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. J Biol Chem 269: 28584-28590, 1994.
59. Saks V, Dzeja P, Schlattner U, Vendelin M, Terzic A, Wallimann T. Cardiac system bioenergetics: metabolic basis of the Frank-Starling law. J Physiol 571: 253-273, 2006.
60. Schlattner U, Dolder M, Wallimann T, Tokarska-Schlattner M. Mitochondrial creatine kinase and mitochondrial outer membrane porin show a direct interaction that is modulated by calcium. J Biol Chem 276: 48027-48030, 2001. (Pubitemid 37370703)
61. 2+-sensitization. Eur J Pharmacol 486: 1-8, 2004.
62. Sorsa T, Pollesello P, Solaro RJ. The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c. Mol Cell Biochem 266: 87-107, 2004. (Pubitemid 39562310)
63. Szilagyi S, Pollesello P, Levijoki J, Haikala H, Bak I, Tosaki A, Borbely A, Edes I, Papp Z. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone. J Cardiovasc Pharmacol 46: 369-376, 2005. (Pubitemid 41262841)
64. Ukkonen H, Saraste M, Akkila J, Knuuti J, Karanko M, Iida H, Lehikoinen P, Nagren K, Lehtonen L, Voipio-Pulkki LM. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 68: 522-531, 2000.
65. Wu ST, Kojima S, Parmley WW, Wikman-Coffelt J. Relationship between cytosolic calcium and oxygen consumption in isolated rat hearts. Cell Calcium 13: 235-247, 1992.